Mode
Text Size
Log in / Sign up
N/A N=46 Randomized Double-blind Treatment

Movement Pattern Training in People With Intra-articular, Prearthritic Hip Disorders

Chronic Hip Joint Pain · Prearthritic Hip Disease

Enrolled (actual)
46
Serious AEs
0.0%
Results posted
May 2020
Primary outcome: Primary: Percentage of Participants Who Are Adherent to Treatment Attendance — 21; 22 Participants — p=1.0

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Rehabilitation (Other)
Age
Pediatric, Adult · 15+ yrs
Sex
All
Sponsor
Washington University School of Medicine
Primary completion
Dec 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Participants Who Are Adherent to Treatment Attendance
21; 22 1.0
SECONDARY
Change in Function Using the Hip Disability and Osteoarthritis Outcome Score (HOOS) Activities in Daily Living Subscale From Baseline to Post-treatment (13 Weeks)
12.5; 12.4 0.32
SECONDARY
Change in Hip Disability and Osteoarthritis Outcome Score (HOOS) Symptoms Subscale From Baseline to Post-treatment (13 Weeks)
15.0; 17.5 0.14

Summary

Intra-articular, prearthritic hip disorders (PAHD) result in substantial dysfunction in young adults and are proposed precursors to hip osteoarthritis (OA). Effective treatment of PAHD is needed to improve function in the young adult and prevent or delay the onset of hip OA, however evidence related to treatment of PAHD is limited. This research will provide the foundation for a future clinical trial to assess the efficacy of movement pattern training, an innovative rehabilitation approach for the treatment of PAHD.

Eligibility Criteria

Inclusion Criteria

  • be 15-40 years old
  • report deep hip joint or anterior groin pain, confirmed upon physical exam
  • report pain > 3/10 and present > 3 months
  • demonstrate functional limitation with modified Harris Hip Score 40
  • Slipped Capital Femoral Epiphysis (SCFE) or Legg-Calve-Perthes Disease (LCP)
  • pain, numbness or tingling that radiates into the thigh
  • known pregnancy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02913222). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search